Stock IPSC CENTURY THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Century Therapeutics, Inc.

Equities

IPSC

US15673T1007

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-11 pm EDT 		5-day change 1st Jan Change
2.58 USD +9.32% Intraday chart for Century Therapeutics, Inc. +13.66% -22.29%
Jun. 18 Century Therapeutics Proposes Secondary Offering of 7.87 Million Shares MT
Jun. 17 Piper Sandler Adjusts Price Target on Century Therapeutics to $12 From $9, Maintains Overweight Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Other Biotechnology & Medical Research

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CENTURY THERAPEUTICS, INC. Stock Century Therapeutics, Inc.
 218M - - -
MODERNA, INC. Stock Moderna, Inc.
 47.07B -
LONZA GROUP AG Stock Lonza Group AG
 42.06B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
 39.98B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
 33.02B -
CELLTRION, INC. Stock Celltrion, Inc.
 27.9B
  1. Stock Market
  2. Equities
  3. IPSC Stock
  4. Charts Century Therapeutics, Inc.
  5. Sector Chart